The melanocortin receptor family: MC1R to MC5R
A researcher's guide to the five melanocortin receptors, MC1R to MC5R, and why subtype selectivity drives so much peptide work.
The melanocortin system is one of the most closely studied signalling networks in receptor pharmacology. Five related G-protein-coupled receptors — MC1R through MC5R — respond to melanocortin peptides and coordinate processes ranging from pigmentation to energy balance. Understanding how these subtypes differ sits at the centre of a great deal of peptide research.
A shared architecture
All five are class A GPCRs that couple to Gs, raising intracellular cAMP when activated. They share endogenous agonists derived from proopiomelanocortin (POMC) — the melanocyte-stimulating hormones and ACTH — and are modulated by the antagonists agouti and AgRP. Because one peptide can engage several subtypes, selectivity is a recurring theme in the literature.
MC1R and MC2R
MC1R is expressed in melanocytes and is investigated for its role in pigmentation and the balance between eumelanin and pheomelanin. MC2R is the ACTH receptor, examined in the context of adrenal steroidogenesis; unusually, it responds only to ACTH and not to the MSH peptides.
MC3R and MC4R
Both subtypes are found in the central nervous system and are studied extensively for their roles in energy homeostasis, feeding behaviour and metabolic signalling in research models. MC4R in particular is among the most intensively mapped receptors in metabolic neuroscience.
MC5R and selectivity
MC5R is studied for its role in exocrine gland function and immunomodulation in laboratory models. Because a single analogue can touch multiple receptors, researchers focus heavily on binding selectivity and functional potency. Related compounds supplied by Vela ship as a lyophilised powder for reconstitution with bacteriostatic water, and every batch carries a certificate of analysis.
Keep reading
More from the
research bench.
Retatrutide: the triple agonist explained
One molecule, three receptor pathways. Why retatrutide is one of the most closely watched compounds in modern metabolic research.
Tirzepatide: the dual GIP/GLP-1 agonist
How engaging two incretin pathways at once set tirzepatide apart, and what researchers study it for.
Why modified peptides last longer: half-life and modifications
How amino-acid substitutions, fatty-acid chains and added size extend a peptide's half-life, and why it matters in research.
